Trinity Biotech (TRIB) Cash from Investing Activities (2021 - 2024)
Trinity Biotech (TRIB) posted Cash from Investing Activities of -$2.7 million for Q4 2024, down 207.07% sequentially from -$891000.0 in Q4 2023, and down 207.07% YoY from $2.6 million in Q1 2024.
Trinity Biotech (TRIB) Cash from Investing Activities (2021 - 2024) Analysis & Trends
Trinity Biotech has reported Cash from Investing Activities for 4 years, with the latest figure at -$2.7 million in Q4 2024.
- Quarterly Cash from Investing Activities fell 207.07% year-over-year to -$2.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$5.7 million (down 33.31% YoY) and the FY2025 annual result came in at -$6.2 million, up 72.91% from the prior year.
- Cash from Investing Activities fell to -$2.7 million in Q4 2024 per TRIB's latest filing, from -$891000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$1801.0 in Q2 2022 and troughed at -$2.7 million in Q4 2024.
- A 4-year average of -$1.2 million and a median of -$1.0 million in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities soared 54.02% in 2022, then slumped 207.07% in 2024.
- Over 4 years, Cash from Investing Activities stood at -$2.5 million in 2021, then soared by 54.02% to -$1.1 million in 2022, then advanced by 21.7% to -$891000.0 in 2023, then plunged by 207.07% to -$2.7 million in 2024.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$2.7 million, -$891000.0, and -$886000.0 for Q4 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Trinity Biotech | 6.82 Mn | 1.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.74 Mn |
| Dec 31, 2024 | -2.74 Mn |
| Dec 31, 2023 | -891,000.00 |
| Dec 31, 2023 | -891,000.00 |
| Sep 30, 2023 | -886,000.00 |
| Sep 30, 2023 | -886,000.00 |
| Dec 31, 2022 | -1.14 Mn |
| Dec 31, 2022 | -1.14 Mn |
| Sep 30, 2022 | -1.32 Mn |
| Sep 30, 2022 | -1.32 Mn |
| Jun 30, 2022 | -1,801.00 |
| Jun 30, 2022 | -1,801.00 |
| Dec 31, 2021 | -2.48 Mn |
| Dec 31, 2021 | -2.48 Mn |
| Jun 30, 2021 | -2,131.00 |
| Jun 30, 2021 | -2,131.00 |